Enhancement of antitumor effect of cytotoxic agents by bestatin. 1985

F Abe, and K Shibuya, and J Ashizawa, and K Takahashi, and H Horinishi, and A Matsuda, and M Ishizuka, and T Takeuchi, and H Umezawa

Bestatin enhanced the antitumor effects of mitomycin C, 5-fluorouracil and cis-dichlorodiammineplatinum against a syngeneic solid tumor of colon adenocarcinoma 26 in BALB/c mice. The enhancement was dependent on administration schedule. Bestatin administration after treatment with the cytotoxic agents was more effective than that made before the treatment.

UI MeSH Term Description Entries
D007930 Leucine An essential branched-chain amino acid important for hemoglobin formation. L-Leucine,Leucine, L-Isomer,L-Isomer Leucine,Leucine, L Isomer
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D008937 Mitomycins A group of methylazirinopyrroloindolediones obtained from certain Streptomyces strains. They are very toxic antibiotics used as ANTINEOPLASTIC AGENTS in some solid tumors. PORFIROMYCIN and MITOMYCIN are the most useful members of the group.
D009374 Neoplasms, Experimental Experimentally induced new abnormal growth of TISSUES in animals to provide models for studying human neoplasms. Experimental Neoplasms,Experimental Neoplasm,Neoplasm, Experimental
D002945 Cisplatin An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle. Platinum Diamminodichloride,cis-Diamminedichloroplatinum(II),cis-Dichlorodiammineplatinum(II),Biocisplatinum,Dichlorodiammineplatinum,NSC-119875,Platidiam,Platino,Platinol,cis-Diamminedichloroplatinum,cis-Platinum,Diamminodichloride, Platinum,cis Diamminedichloroplatinum,cis Platinum
D003110 Colonic Neoplasms Tumors or cancer of the COLON. Cancer of Colon,Colon Adenocarcinoma,Colon Cancer,Cancer of the Colon,Colon Neoplasms,Colonic Cancer,Neoplasms, Colonic,Adenocarcinoma, Colon,Adenocarcinomas, Colon,Cancer, Colon,Cancer, Colonic,Cancers, Colon,Cancers, Colonic,Colon Adenocarcinomas,Colon Cancers,Colon Neoplasm,Colonic Cancers,Colonic Neoplasm,Neoplasm, Colon,Neoplasm, Colonic,Neoplasms, Colon
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D005260 Female Females
D005472 Fluorouracil A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid. 5-FU,5-FU Lederle,5-FU Medac,5-Fluorouracil,5-Fluorouracil-Biosyn,5-HU Hexal,5FU,Adrucil,Carac,Efudex,Efudix,Fluoro-Uracile ICN,Fluoroplex,Fluorouracil Mononitrate,Fluorouracil Monopotassium Salt,Fluorouracil Monosodium Salt,Fluorouracil Potassium Salt,Fluorouracil-GRY,Fluorouracile Dakota,Fluorouracilo Ferrer Far,Fluoruracil,Fluracedyl,Flurodex,Haemato-FU,Neofluor,Onkofluor,Ribofluor,5 FU Lederle,5 FU Medac,5 Fluorouracil,5 Fluorouracil Biosyn,5 HU Hexal,Dakota, Fluorouracile,Fluoro Uracile ICN,Fluorouracil GRY,Haemato FU
D000230 Adenocarcinoma A malignant epithelial tumor with a glandular organization. Adenocarcinoma, Basal Cell,Adenocarcinoma, Granular Cell,Adenocarcinoma, Oxyphilic,Adenocarcinoma, Tubular,Adenoma, Malignant,Carcinoma, Cribriform,Carcinoma, Granular Cell,Carcinoma, Tubular,Adenocarcinomas,Adenocarcinomas, Basal Cell,Adenocarcinomas, Granular Cell,Adenocarcinomas, Oxyphilic,Adenocarcinomas, Tubular,Adenomas, Malignant,Basal Cell Adenocarcinoma,Basal Cell Adenocarcinomas,Carcinomas, Cribriform,Carcinomas, Granular Cell,Carcinomas, Tubular,Cribriform Carcinoma,Cribriform Carcinomas,Granular Cell Adenocarcinoma,Granular Cell Adenocarcinomas,Granular Cell Carcinoma,Granular Cell Carcinomas,Malignant Adenoma,Malignant Adenomas,Oxyphilic Adenocarcinoma,Oxyphilic Adenocarcinomas,Tubular Adenocarcinoma,Tubular Adenocarcinomas,Tubular Carcinoma,Tubular Carcinomas

Related Publications

F Abe, and K Shibuya, and J Ashizawa, and K Takahashi, and H Horinishi, and A Matsuda, and M Ishizuka, and T Takeuchi, and H Umezawa
March 1988, Gan to kagaku ryoho. Cancer & chemotherapy,
F Abe, and K Shibuya, and J Ashizawa, and K Takahashi, and H Horinishi, and A Matsuda, and M Ishizuka, and T Takeuchi, and H Umezawa
December 1977, British journal of cancer,
F Abe, and K Shibuya, and J Ashizawa, and K Takahashi, and H Horinishi, and A Matsuda, and M Ishizuka, and T Takeuchi, and H Umezawa
January 2005, In vivo (Athens, Greece),
F Abe, and K Shibuya, and J Ashizawa, and K Takahashi, and H Horinishi, and A Matsuda, and M Ishizuka, and T Takeuchi, and H Umezawa
July 1989, Journal of immunology (Baltimore, Md. : 1950),
F Abe, and K Shibuya, and J Ashizawa, and K Takahashi, and H Horinishi, and A Matsuda, and M Ishizuka, and T Takeuchi, and H Umezawa
August 1996, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology,
F Abe, and K Shibuya, and J Ashizawa, and K Takahashi, and H Horinishi, and A Matsuda, and M Ishizuka, and T Takeuchi, and H Umezawa
May 1970, Saishin igaku. Modern medicine,
F Abe, and K Shibuya, and J Ashizawa, and K Takahashi, and H Horinishi, and A Matsuda, and M Ishizuka, and T Takeuchi, and H Umezawa
July 2018, Molecular medicine reports,
F Abe, and K Shibuya, and J Ashizawa, and K Takahashi, and H Horinishi, and A Matsuda, and M Ishizuka, and T Takeuchi, and H Umezawa
June 1971, Gan,
F Abe, and K Shibuya, and J Ashizawa, and K Takahashi, and H Horinishi, and A Matsuda, and M Ishizuka, and T Takeuchi, and H Umezawa
May 2007, Bioorganic & medicinal chemistry letters,
F Abe, and K Shibuya, and J Ashizawa, and K Takahashi, and H Horinishi, and A Matsuda, and M Ishizuka, and T Takeuchi, and H Umezawa
January 1986, Progress in clinical and biological research,
Copied contents to your clipboard!